Crowdmark, a graduate of the University of Toronto Early-Stage Technology (UTEST) program’s first cohort, was the focus of a February 17 article by Ivor Tossell, The Globe and Mail‘s technology culture columnist.
Dr. James Colliander, co-founder and CEO of Crowdmark.
Created by U of T professor James Colliander, Crowdmark allows educators to quickly and efficiently grade large amounts of tests and exams. Tossell highlighted Crowdmark’s innovation and ease-of-use for the grader. The product is cloud-based, meaning that a team of educators marking the same group of exams don’t have to be in the same room at the same time. Instead, grading can be done remotely.
Tossell spoke with Colliander and Lyssa Neel, Crowdmark’s chief operating officer and a former MI project manager. Here’s an excerpt from the article:
James Colliander, a professor at the University of Toronto, found himself staring at about 5,000 pages of papers from a national math exam. Traditionally, a cadre of markers would sit around a large table for marathon grading sessions, assembly line style, each one tackling the answer to one question before passing it on to the next marker.
Mr. Colliander hacked together an expedient: He scanned the pages into a software framework and distributed them to markers digitally. He was essentially able to parallelize the marking process.
Dr. Lyssa Neel, COO of Crowdmark and former MI project manager.
“The markers didn’t all have to be in the same place, so they could move much faster,” says Lyssa Neel, COO of Crowdmark, the company that, with Mr. Colliander as CEO, has brought the idea to market.
Crowdmark is an online service that takes the idea of distributed marking and scales it to an institutional level.
Indiegogo campaign raised $53,390 from over 500 worldwide donors
WaveCheck co-inventor, Dr. Gregory Czarnota, appeared on CTV National News on December 15.
CTV National News featured WaveCheck’s crowdfunding campaign on December 15 in a report by Avis Favaro. The report included an interview with MaRS Innovation’s President and CEO, Dr. Raphael Hofstein (at the 1:37 mark).
William Tran, a researcher associated with the project at Sunnybrook Health Sciences Centre, was also interviewed on Canada AM on December 16.
WaveCheck, which closed its campaign December 4, was invented by Dr. Gregory Czarnota of Sunnybrook Health Sciences Centre and Prof. Michael C. Kolios of Ryerson University. WaveCheck uses ultrasound technology to show people with breast cancer if their chemotherapy is working within weeks.
While the Indiegogo campaign has concluded, Sunnybrook Foundation is now accepting donations flagged “WaveCheck” on behalf of the researchers through its website.
At campaign close, WaveCheck ranked in the top 0.005 per cent of health-related campaigns on Indiegogo, and was covered by CBC television and Metro Morning, theToronto Star, Sing-Tao and MedCity News.
Dr. Keith Jarvi (left), Head of Urology and Director of the Murray Koffler Urologic Wellness Centre and Dr. Andrei Darbovich, lead author of the paper.
Mount Sinai’s Lunenfeld-Tanenbaum Research Institute has developed a new test that could make a big difference to men facing infertility.
A study published in a leading international journal, Science Translational Medicine, details the discovery of a key biomarker that can pinpoint the cause of infertility without the need for invasive surgery.
About half a million Canadian men are infertile, according to clinician-research Dr. Keith Jarvi. As a urologist who treats men with infertility, he knows how valuable this simple, inexpensive test could be. “Testing a semen sample can be done in the doctor’s clinic as it’s noninvasive and much easier for the patient than surgery,” he says.
Dr. Jarvi directs the Murray Koffler Urologic Wellness Centre, is head of Urology, and associate scientist at the Lunenfeld-Tanenbaum Research Institute. He is a professor of Surgery at University of Toronto.
MaRS Innovation, which commercializes discoveries made by University of Toronto hospitals and research institutes, is already working on the project, which Jarvi believes may lead to commercial tests within the next couple of years. [For more information, contact Barry Elkind].
“Breast Cancer Awareness Month’s positivity makes it easy to overlook the fact that 60 to 70 per cent of chemotherapy treatments fail,” says Dr. Gregory Czarnota, chief of Radiation Oncology at Sunnybrook Health Sciences Centre and co-inventor of WaveCheck with Professor Michael C. Kolios of Ryerson University. “WaveCheck’s technology can tell people with breast cancer and their doctors if a particular chemotherapy is working in as little as four weeks.”
MI’s Fanny Sie and Shotlst Co-founder Matt Ratto talk bioprinting, healthcare, civil rights and home manufacturing with Steve Paikin
Fanny Sie, project manager in physical sciences and medical devices with specialization in medical imaging, appeared on TVO’s The Agenda on June 5, 2013 to discuss 3D printing.
MaRS Innovation Project Manager Fanny Sie discusses 3D printing, the Bioprinter technology and the implications for society and human health on TVO’s The Agenda.
Sie manages the Bioprinter technology, which was touched upon during the interview. The bioprinter was invented by Axel Guenther, a professor in the University of Toronto’s Department of Mechanical and Industrial Engineering, PhD student Lian Leng and a team of other researchers.
The Globe and Mail covered the Bioprinter’s development on January 20, 2013; an excerpt of their interviews with Leng and Guenther was included in the program.
Bioprinting and the Internet of Things
The Agenda’s 3D printing episode also included a second segment exploring its implications for home manufacturing and civil liberties. The guests included Matt Ratto, assistant professor in U of T’s Faculty of Information and co-inventor and CEO of Shotlst (a UTEST company).
Professor Matt Ratto, co-founder of Shotlst and director of the Critical Making Lab, discusses 3D printing, home manufacturing and civil liberties on TVO’s The Agenda.
Ratto described his experience downloading and printing the Liberator, a gun that can be printed using 3D printing technology, to better understand the process required and the resulting gun’s capabilities.
Fanny Sie, project manager in physical sciences and medical devices , MaRS Innovation.
MaRS Innovation’s Fanny Sie, project manager in physical sciences and medical devices with specialization in medical imaging, is appearing on TVO’s The Agenda with Steve Paikin at 8 pm on June 5, 2013 to discuss 3D printing and the technology’s applications in healthcare and other aspects of human society.
Sie manages the Bioprinter technology, which was invented by Axel Guenther, a professor in the University of Toronto’s Department of Mechanical and Industrial Engineering, PhD student Lian Leng and a team of other researchers. The Globe and Mail covered the Bioprinter’s development on January 20, 2013.
Health reporter Beatrice Politi also covered the Bio Printer project for Global News Toronto January 21. Her video segment includes an interview with PhD student Lian Leng and a look at the existing Bio Printer prototype.
Asked what the technological tools in university classrooms will look and feel like by 2020, Matt Ratto admits he’s no futurist. But the assistant professor at the University of Toronto’s Faculty of Information is helping shape the future – by changing students’ relationship with technology.
MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek) have announced a strategic partnership to co‐develop, and bring to the Chinese market, a novel therapeutic cream aimed at reducing scar formation post surgery.
Crowdmark, a graduate of the University of Toronto Early-Stage Technology (UTEST) program’s first cohort, was the focus of a February 17 article by Ivor Tossell, The Globe and Mail‘s technology culture columnist.
